BLTE
Price
$60.95
Change
-$0.38 (-0.62%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
1.98B
90 days until earnings call
DAWN
Price
$6.74
Change
+$0.44 (+6.98%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
638.58M
95 days until earnings call
Ad is loading...

BLTE vs DAWN

Header iconBLTE vs DAWN Comparison
Open Charts BLTE vs DAWNBanner chart's image
Belite Bio
Price$60.95
Change-$0.38 (-0.62%)
Volume$600
Capitalization1.98B
Day One Biopharmaceuticals
Price$6.74
Change+$0.44 (+6.98%)
Volume$52.54K
Capitalization638.58M
BLTE vs DAWN Comparison Chart
Loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLTE vs. DAWN commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a Hold and DAWN is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (BLTE: $61.33 vs. DAWN: $6.30)
Brand notoriety: BLTE and DAWN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 51% vs. DAWN: 293%
Market capitalization -- BLTE: $1.98B vs. DAWN: $638.58M
BLTE [@Biotechnology] is valued at $1.98B. DAWN’s [@Biotechnology] market capitalization is $638.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileDAWN’s FA Score has 0 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • DAWN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BLTE and DAWN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 4 TA indicator(s) are bullish while DAWN’s TA Score has 4 bullish TA indicator(s).

  • BLTE’s TA Score: 4 bullish, 6 bearish.
  • DAWN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than BLTE.

Price Growth

BLTE (@Biotechnology) experienced а -0.24% price change this week, while DAWN (@Biotechnology) price change was -19.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.88%. For the same industry, the average monthly price growth was +15.29%, and the average quarterly price growth was -13.75%.

Reported Earning Dates

BLTE is expected to report earnings on Aug 06, 2025.

DAWN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-3.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($1.98B) has a higher market cap than DAWN($639M). BLTE YTD gains are higher at: -2.805 vs. DAWN (-50.276). BLTE has higher annual earnings (EBITDA): -35.42M vs. DAWN (-215.24M). DAWN has higher revenues than BLTE: DAWN (131M) vs BLTE (0).
BLTEDAWNBLTE / DAWN
Capitalization1.98B639M310%
EBITDA-35.42M-215.24M16%
Gain YTD-2.805-50.2766%
P/E RatioN/AN/A-
Revenue0131M-
Total CashN/A532M-
Total DebtN/A2.6M-
TECHNICAL ANALYSIS
Technical Analysis
BLTEDAWN
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAHEX16.970.03
+0.18%
Calamos Hedged Equity A
JETAX14.87N/A
N/A
abrdn Focused Em Markets ex-China A
JDPAX15.08N/A
N/A
Janus Henderson Mid Cap Value A
SMINX12.36N/A
N/A
SEI Tax-Managed Intl Mgd Vol F (SIMT)
MSJFX56.47N/A
N/A
Invesco Main Street R5

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+0.36%
RAIN - BLTE
48%
Loosely correlated
+17.17%
ACOG - BLTE
24%
Poorly correlated
+10.80%
ALEC - BLTE
24%
Poorly correlated
-2.86%
TVTX - BLTE
23%
Poorly correlated
+1.40%
KALA - BLTE
22%
Poorly correlated
-0.00%
More